BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9198124)

  • 1. Thrombopoietin (Mpl-ligand) and the regulation of platelet production.
    Cohen-Solal K; Debili N; Vainchenker W; Wendling F
    Thromb Haemost; 1997 Jul; 78(1):37-41. PubMed ID: 9198124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compared effects of Mpl ligand and other cytokines on human MK differentiation.
    Vitrat N; Cohen-Solal K; Norol F; Guichard J; Cramer E; Vainchenker W; Wendling F; Debili N
    Stem Cells; 1998; 16 Suppl 2():37-51. PubMed ID: 11012176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin: biology and clinical potentials.
    Miyazaki H; Kato T
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Mpl ligands on platelet production and function in nonhuman primates.
    Harker LA; Marzec UM; Kelly AB
    Stem Cells; 1998; 16 Suppl 2():107-19. PubMed ID: 11012183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mpl ligand or thrombopoietin: biological activities.
    Wendling F; Cohen-Solal K; Villeval JL; Debili N; Vainchenker W
    Biotherapy; 1998; 10(4):269-77. PubMed ID: 9592015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin: its role from early hematopoiesis to platelet production.
    Wendling F
    Haematologica; 1999 Feb; 84(2):158-66. PubMed ID: 10091415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
    Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
    Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megakaryocyte development and platelet production.
    Deutsch VR; Tomer A
    Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical use of thrombopoietin (c-Mpl Ligand)].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1998; 51(11-12):501-8. PubMed ID: 10081270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombopoietin and megakaryocyte differentiation].
    Vainchenker W; Debili N; Norol F; Wendling F
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1575-81. PubMed ID: 9824885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biology of thrombopoietin and its receptors].
    Robak T
    Postepy Hig Med Dosw; 1996; 50(6):649-63. PubMed ID: 9064684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-3 does not contribute to platelet production in c-Mpl-deficient mice.
    Chen Q; Solar G; Eaton DL; de Sauvage FJ
    Stem Cells; 1998; 16 Suppl 2():31-6. PubMed ID: 11012175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
    Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
    Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin in vitro and in vivo.
    Alexander WS; Begley CG
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin, a direct stimulator of viability and multilineage growth of primitive bone marrow progenitor cells.
    Jacobsen SE; Borge OJ; Ramsfjell V; Cui L; Cardier JE; Veiby OP; Murphy MJ; Lok S
    Stem Cells; 1996; 14 Suppl 1():173-80. PubMed ID: 11012218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Megakaryocyte development and platelet production in normal and disease states].
    Deutsch V; Katz BZ; Tomer A
    Harefuah; 2010 May; 149(5):291-7, 336. PubMed ID: 20929068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?
    Folman CC; Linthorst GE; van Mourik J; van Willigen G; de Jonge E; Levi M; de Haas M; von dem Borne AE
    Thromb Haemost; 2000 Jun; 83(6):923-30. PubMed ID: 10896250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.